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Background: Hypercholesterolemia causes inflammation and insulin resistance in the vasculature. Previous data
suggest that vascular endothelium is a physiological target of insulin. Dyslipidemia and atherosclerosis are disorders
with endothelial dysfunction that are associated with an increased production of superoxide anion, and early deficit
of nitric oxide (NO) production. We examined alteration of plasma levels of insulin, C-reactive protein (CRP) and
total NO metabolites (NOx), as well as fatty streak formation in the rabbit model of hypercholesterolemia.
Methods: White male rabbits were fed either a high-cholesterol diet (HC; 1% cholesterol, n = 6) or control diet
(c, n = 6) for one month. The serum levels of Cholesterol, LDL, HDL, NOx, insulin and CRP were measured before
and after study. By the end of study, rabbits' aorta was explored for fatty streak formation.
Results: The cholesterol-rich diet induced a significant increase in total cholesterol, LDL, and HDL as well as fatty
streak lesions in HC group while there were no significant changes of these parameters in control group (p <0.05).
There was significant difference in plasma levels of CRP, insulin and total NO metabolite between two groups of
experiment. Negative significant correlation of CRP and insulin also was observed in HC rabbits (r =−0.99, p <0.05).
Conclusion: Parallel NOx and insulin increment and negative correlation of CRP and insulin in HC rabbits may be
suggestive a protective role of hyperinsulinemia in early atherosclerosis.
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Considerable data suggest vascular endothelium as a
physiological target of insulin [1,2]. In addition to the
eminent metabolic effects, insulin has important vascu-
lar actions. Insulin stimulate production of nitric oxide
(NO) from endothelium by phosphatidyl inositol 3-
kinase (PI3K)-dependent signaling pathways [3]. Patho-
physiologic conditions such as hyperlipidemia, and
inflammation selectively impair PI3K dependent insulin
signaling pathways, creating reciprocal relationships be-
tween insulin resistance and endothelial dysfunction
(ED)[3], and ED is associated with deficit of NO produc-
tion [4].* Correspondence: dana.nasim@gmail.com
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distribution, and reproduction in any mediumIt is reported that NO has direct effects on the progres-
sion of atherosclerosis [5], but chronic inhibition of NO in
the presence of a high-cholesterol diet has been shown to
induce development of atherosclerosis [6]. Furthermore,
reducing endothelial NO levels is a known mechanism for
inducing insulin resistance [7]. This fact is tempting to
hypothesize a potential link between insulin resistance
and atherosclerosis. It has been suggested that reduced
bioavailability of NO by insulin resistance may be an
additional pathogenic factor in atherosclerosis [7,8]. The
exact molecular relationship between insulin, ED and ath-
erosclerosis is presently unknown [9]. In order to elucidate
this relationship, studying the early variation of insulin
during induction of hypercholesterolemia may help
cognizance the pathogenesis of atherosclerosis.
Therefore in this study we examined plasma levels of in-
sulin, C-reactive protein (CRP) and total NO metabolitestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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model of hypercholesterolemia.
Methods
Animals and experimental design
The study was reviewed and approved by the Ethics
Committee of Isfahan University of Medical Sciences.
Twelve white male rabbits weighing between 1.9 ± 0.1 kg
were obtained from the Pasteur Institute of Iran. After
1-week acclimatization period and overnight fasting,
blood samples were taken as pre-experimental sampling.
Blood samples were collected in heparinated tubes, cen-
trifuged (10,000 _ g), and the resulting plasma was
stored at −70°C until measurement. The animals were
randomized into two groups of experiments. First group
(HC group) fed rabbit chow supplemented with 1% chol-
esterol, and the other group (control group) received
rabbit chow only. All animals received food and water
ad libitum. After one month of experiment, the blood
samples were taken and stored again. The animals were
euthanized by an overdose of sodium pentobarbital and
ex-sanguinated. The animal's aortas were harvested for
pathological investigation. Triglyceride, total cholesterol,
high density lipoprotein (HDL) cholesterol and, low
density lipoprotein (LDL) levels were measured using a
standard enzymatic kit (Pars Azmoon Co, Iran). NOx
measurement was done by total NO/nitrite/nitrate assay
kit (R&D Systems, Minneapolis, USA) which based on
the enzymatic conversion of nitrate to nitrite by nitrate
reductase as previously described [10]. CRP (IBL Co,
Germany) was measured using an enzyme-linked immuno-
sorbent assay kit according to manufacturer’s instruction.
Insulin was measured by the electrochemiluminescence im-
munoassay method using the Elecsys insulin reagents kitTable 1 The serum levels of total cholesterol, LDL, HDL, Insulin i
P value(before and after)
Total cholesterol (mg/dl)
Case 109.4 ± 12.04
control 118.6 ± 12.1
LDL-cholesterol(mg/dl)
Case 89.2 ± 8.2
control 86.6 ± 7.6
HDL-cholesterol(mg/dl)
Case 15.7 ± 1.4
control 13.0 ± 2.8
Insulin(pmol/ml)
Case 0.80 ± 0.06
control 0.98 ± 0.2
*Significant difference between two groups of experiment (p <0.05). Student’s t-tes
groups. Values are mean ± S.E.(Roche Diagnostics, Mannheim, Germany) on an auto-
mated Roche Modular Analytics Module E170 (Roche
Diagnostics). The detection limit was 0.2 pmol/L.
Pathologic investigation
The entire aortas, from the aortic arch to the external
iliac arteries, were fixed in buffered 10% formalin for
24 h, and then embedded in paraffin. The paraffin-
embedded specimens were sectioned at 5 μm. 20 sec-
tions were stained with haematoxylin and eosin, and
examined by light microscopy for the fatty streak lesions
formation and the intima and media thickness of aorta
measurement. Then the intima / media thickness (IMT)
ratios were calculated as the atheroma formation index
for each animal.
Statistical analysis
The data are reported as the mean ± SEM. A statistical
software package, SPSS (version 13), was used to perform
statistical analysis. The data were tested for normality and
homogeneity of variance. Paired and unpaired Student's t-
test was used to assess the significance of any changes
within and between groups respectively. Statistical signifi-
cance was accepted at p <0.05.
Results
The cholesterol-rich diet induced a significant increase in
total cholesterol, LDL-cholesterol, and HDL-cholesterol in
hypercholesterolemic group while there were no signifi-
cant changes of these parameters in control group. There
was significant difference in total cholesterol, LDL-, and
HDL between two groups of experiment (Table 1).
There was no significant difference in plasma level
of insulin before and after experiment in controln two groups of the study at baseline and after experiment
After experiment Before experiment
2130.9 ± 171.8* 0.002
138.02 ± 9.8 0.4
1418.9 ± 164.6* 0.003
88.7 ± 5.1 0.07
91.7 ± 8.0* 0.019
12.0 ± 3.4 0.6
1.16 ± 0.07* 0.04
0.89 ± 0.2 0.1
t was used to assess the significance of the parameter changes between
Figure 1 Total nitric oxide metabolite (μmol/l) levels before and after of experiment in case and control groups. Paired and unpaired
Student’s t-test was used to assess the significance of parameter changes within and between groups respectively. (P <0.05).
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cantly increased in case group (Table 1). There was
significant difference in plasma levels of insulin be-
tween two groups of experiment (p <0.05) (Table 1).
Similarly, there was no significant difference in plasma
level of total NO metabolite before and after experiment
in control group while the total NO metabolite level was
significantly increased (p <0.05) (Figure 1). There were
significantly more plasma levels of total NO metabolite
in cases compare to control group (p <0.05) (Figure 1).
The plasma level of CRP significantly increased in case
group (p <0.05) (Figure 2) whereas there was No signifi-
cant difference in plasma level of CRP, insulin and total
NO metabolite were found before and after experiment
in control group (Figure 2). There was significant
increased plasma levels of CRP in cases compare to con-
trol group (p <0.05) (Figure 2).
At the end of study, there was no fatty streak
lesions in the control group aortas while the IMT
ratio was 0.27 ± 0.1 in HC group (p = 0.05).
There was a significant negative correlation between
plasma levels of insulin and CRP concentration (r =−0.99,
p=0.03) by the end of experiment in control group.Figure 2 C-reactive protein levels before and after of experiment in c
used to assess the significance of any changes within and between groupsDiscussion
This study was designed to investigate the insulin alter-
ation as a consequence of hypercholesterolemic diet in
rabbit model of early atherosclerosis. The cholesterol-
rich diet resulted in a significant increase in total choles-
terol, LDL-cholesterol, and HDL-cholesterol as well as
the development of early lesions that were representative
of fatty streak initiation similar to those in humans.
Thus, the model allowed us to examine some factor al-
teration during the initiation of atherosclerosis. In
current experiment, CRP significantly increased in
hypercholesterolemic rabbits while there was no signifi-
cant change in control group.CRP has not only been
proposed as risk factors of cardiovascular disease, but
has also been associated with the variables of insulin re-
sistance syndrome [11]. Since hypercholesterolemia is a
major participator in the inflammatory process of ath-
erosclerosis, several in vitro and in vivo studies have
been showed the increased level of CRP in hypercholes-
terolemic animals and patients [12,13].
As the results of our study indicated, 30 days of
cholesterol-feeding enhanced the content of total nitrite, as
has been demonstrated previously [14-16]. It has beenase and control groups. Paired and unpaired Student’s t-test was
respectively (P <0.05).
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mechanism to compensate for continuous inactivation of
NO by oxygen-derived free radicals [17,18].Another pro-
posed mechanisms responsible for the elevation of nitrite
may be NO production by other isoforms of Nitric Oxide
Synthase (NOS)enzymes. Increased NOS mRNA and pro-
tein of atherosclerotic vessels reported in other experiments
showing that aortas of hypercholesterolemic rabbits release
larger quantities of nitrogen oxides than do normal vessels
in early atherosclerosis [19].
Interestingly, in parallel to total NO metabolite alter-
ation, the hypercholesterolemia induced insulin increment
in rabbits. At the cellular level, it has been shown that ex-
posure to insulin increases eNOS mRNA and protein syn-
thesis [20,21]. Furthermore, insulin increased eNOS
production through increasing the activity of AP-1, a tran-
scription factor that bind to the eNOS promoter [20].
Furthermore, in humans, infusion of insulin causes
NO dependent vasodilatation and increased blood flow
[22]. In both humans [23] and in animal models of insu-
lin resistance [24], there is a specific impairment of
PI3K-dependent signaling pathways. Thus, insulin resist-
ance would be associated with a decrease in eNOS phos-
phorylation and decreased endothelial NO production.
So, it seems that early hyperinsulinemia in the beginning
of the atherosclerosis may be a protective mechanism
for endothelial function. However, it has been shown
that prolonged exposure of endothelial cells to high in-
sulin levels induces a downregulation of the PI3K/Akt/
eNOS axis. Such impairment of insulin signaling in pro-
longed hyperinsulinemia may result in ED and promote
atherogenesis [25].
In this study, there was a significant negative correl-
ation between plasma levels of insulin and CRP concen-
tration several experiments demonstrated the anti-
inflammatory effects of insulin [26-30]. It has been
showed that insulin suppressed the expression of the
pro-inflammatory intracellular adhesion molecule
(ICAM)-1, the chemokine, monocyte chemoattractant
protein-1 (MCP-1), and the key pro-inflammatory tran-
scription factor, nuclear factor [kappa]B (NF[kappa]B) in
human aortic endothelial cells at physiologically relevant
concentrations [26,27]. In patients with acute myocardial
infarction, insulin also suppressed C-reactive protein
(CRP) and serum amyloid A (SAA) by 40% within 24 h
of the start of the insulin infusion while glucose concen-
trations rendered unchanged [28]. This effect of insulin
was corroborated in patients with myocardial infarction
as well as in patients undergoing coronary artery bypass
grafts in two studies [28-30].
In summary, insulin may promotes endothelial func-
tion, through increased NO production, which may has
anti-inflammatory effects and cause slower atheroscler-
otic progression.Competing interests
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